Loading…
Anti-Müllerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment: A Systematic Narrative Review
Since serum anti-Müllerian hormone (AMH) levels enable quantitative evaluation of ovarian damage, we conducted a computer-based search, using key words, of all articles published in English through the PubMed database from inception until September 2013 to summarize available studies evaluating ovar...
Saved in:
| Published in: | Reproductive sciences (Thousand Oaks, Calif.) Calif.), 2015-05, Vol.22 (5), p.519-526 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c445t-517d3fd36a7a4e1a133f85ddb0a4049a5197e076e394b5dfaf8fd2a08cff4b7b3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c445t-517d3fd36a7a4e1a133f85ddb0a4049a5197e076e394b5dfaf8fd2a08cff4b7b3 |
| container_end_page | 526 |
| container_issue | 5 |
| container_start_page | 519 |
| container_title | Reproductive sciences (Thousand Oaks, Calif.) |
| container_volume | 22 |
| creator | Iwase, Akira Nakamura, Tomoko Nakahara, Tatsuo Goto, Maki Kikkawa, Fumitaka |
| description | Since serum anti-Müllerian hormone (AMH) levels enable quantitative evaluation of ovarian damage, we conducted a computer-based search, using key words, of all articles published in English through the PubMed database from inception until September 2013 to summarize available studies evaluating ovarian reserve after ovarian toxic interventions to discuss the usefulness of serum AMH levels. We found that most of the studies demonstrated a decline in serum AMH levels when compared to control or pretreatment levels, with levels dependent on the type of treatment modality. Measurement of serum AMH levels enables quantitative evaluation of ovarian damage caused by ovarian toxic interventions, such as chemotherapy and radiotherapy, instead of qualitative evaluation using menstrual condition or basal follicle-stimulating hormone levels. Serum AMH levels are becoming indispensable to assess the ovarian reserve of patients who desire preservation of ovarian function for fertility and endogenous sex steroid hormones. |
| doi_str_mv | 10.1177/1933719114549856 |
| format | article |
| fullrecord | <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1177_1933719114549856</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1933719114549856</sage_id><sourcerecordid>10.1177_1933719114549856</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-517d3fd36a7a4e1a133f85ddb0a4049a5197e076e394b5dfaf8fd2a08cff4b7b3</originalsourceid><addsrcrecordid>eNqNkMFKw0AQhhdRbK3ePcm-QHQnu5tNjqGoFSoFqXgMm-xsSWmSspsWfTdvvpipaXvwIJ5mmPm-gfkJuQZ2C6DUHSScK0gAhBRJLKMTMtyNAhUyeXrou_2AXHi_ZKyjwvicDEIZhnHEYUje0rotg-evz9UKXalrOmlc1dRIdW1o6j16X2Hd0sbS2Vb_EC_o0W2RprZFd5zOm_eyoHOHut0Jl-TM6pXHq30dkdeH-_l4Ekxnj0_jdBoUQsg2kKAMt4ZHWmmBoIFzG0tjcqYFE4mWkChkKkKeiFwaq21sTahZXFgrcpXzEWH93cI13ju02dqVlXYfGbBsl1H2O6NOuemV9Sav0ByFQygdAD3gu1W9QJctm42ruzf-OhrsHb3Af_Df1al-4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Anti-Müllerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment: A Systematic Narrative Review</title><source>Springer Link</source><creator>Iwase, Akira ; Nakamura, Tomoko ; Nakahara, Tatsuo ; Goto, Maki ; Kikkawa, Fumitaka</creator><creatorcontrib>Iwase, Akira ; Nakamura, Tomoko ; Nakahara, Tatsuo ; Goto, Maki ; Kikkawa, Fumitaka</creatorcontrib><description>Since serum anti-Müllerian hormone (AMH) levels enable quantitative evaluation of ovarian damage, we conducted a computer-based search, using key words, of all articles published in English through the PubMed database from inception until September 2013 to summarize available studies evaluating ovarian reserve after ovarian toxic interventions to discuss the usefulness of serum AMH levels. We found that most of the studies demonstrated a decline in serum AMH levels when compared to control or pretreatment levels, with levels dependent on the type of treatment modality. Measurement of serum AMH levels enables quantitative evaluation of ovarian damage caused by ovarian toxic interventions, such as chemotherapy and radiotherapy, instead of qualitative evaluation using menstrual condition or basal follicle-stimulating hormone levels. Serum AMH levels are becoming indispensable to assess the ovarian reserve of patients who desire preservation of ovarian function for fertility and endogenous sex steroid hormones.</description><identifier>ISSN: 1933-7191</identifier><identifier>EISSN: 1933-7205</identifier><identifier>DOI: 10.1177/1933719114549856</identifier><identifier>PMID: 25228631</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Anti-Mullerian Hormone - blood ; Antineoplastic Agents - adverse effects ; Biomarkers - blood ; Down-Regulation ; Embryology ; Female ; Fertility Preservation ; Humans ; Infertility, Female - blood ; Infertility, Female - chemically induced ; Infertility, Female - physiopathology ; Medicine & Public Health ; Obstetrics/Perinatology/Midwifery ; Ovarian Reserve - drug effects ; Ovarian Reserve - radiation effects ; Ovary - drug effects ; Ovary - metabolism ; Ovary - pathology ; Ovary - physiopathology ; Predictive Value of Tests ; Radiation Injuries - blood ; Radiation Injuries - etiology ; Radiation Injuries - physiopathology ; Radiotherapy - adverse effects ; Reproductive Medicine ; Review ; Risk Factors</subject><ispartof>Reproductive sciences (Thousand Oaks, Calif.), 2015-05, Vol.22 (5), p.519-526</ispartof><rights>The Author(s) 2014</rights><rights>Society for Reproductive Investigation 2015</rights><rights>The Author(s) 2014.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-517d3fd36a7a4e1a133f85ddb0a4049a5197e076e394b5dfaf8fd2a08cff4b7b3</citedby><cites>FETCH-LOGICAL-c445t-517d3fd36a7a4e1a133f85ddb0a4049a5197e076e394b5dfaf8fd2a08cff4b7b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25228631$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iwase, Akira</creatorcontrib><creatorcontrib>Nakamura, Tomoko</creatorcontrib><creatorcontrib>Nakahara, Tatsuo</creatorcontrib><creatorcontrib>Goto, Maki</creatorcontrib><creatorcontrib>Kikkawa, Fumitaka</creatorcontrib><title>Anti-Müllerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment: A Systematic Narrative Review</title><title>Reproductive sciences (Thousand Oaks, Calif.)</title><addtitle>Reprod. Sci</addtitle><addtitle>Reprod Sci</addtitle><description>Since serum anti-Müllerian hormone (AMH) levels enable quantitative evaluation of ovarian damage, we conducted a computer-based search, using key words, of all articles published in English through the PubMed database from inception until September 2013 to summarize available studies evaluating ovarian reserve after ovarian toxic interventions to discuss the usefulness of serum AMH levels. We found that most of the studies demonstrated a decline in serum AMH levels when compared to control or pretreatment levels, with levels dependent on the type of treatment modality. Measurement of serum AMH levels enables quantitative evaluation of ovarian damage caused by ovarian toxic interventions, such as chemotherapy and radiotherapy, instead of qualitative evaluation using menstrual condition or basal follicle-stimulating hormone levels. Serum AMH levels are becoming indispensable to assess the ovarian reserve of patients who desire preservation of ovarian function for fertility and endogenous sex steroid hormones.</description><subject>Anti-Mullerian Hormone - blood</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Biomarkers - blood</subject><subject>Down-Regulation</subject><subject>Embryology</subject><subject>Female</subject><subject>Fertility Preservation</subject><subject>Humans</subject><subject>Infertility, Female - blood</subject><subject>Infertility, Female - chemically induced</subject><subject>Infertility, Female - physiopathology</subject><subject>Medicine & Public Health</subject><subject>Obstetrics/Perinatology/Midwifery</subject><subject>Ovarian Reserve - drug effects</subject><subject>Ovarian Reserve - radiation effects</subject><subject>Ovary - drug effects</subject><subject>Ovary - metabolism</subject><subject>Ovary - pathology</subject><subject>Ovary - physiopathology</subject><subject>Predictive Value of Tests</subject><subject>Radiation Injuries - blood</subject><subject>Radiation Injuries - etiology</subject><subject>Radiation Injuries - physiopathology</subject><subject>Radiotherapy - adverse effects</subject><subject>Reproductive Medicine</subject><subject>Review</subject><subject>Risk Factors</subject><issn>1933-7191</issn><issn>1933-7205</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkMFKw0AQhhdRbK3ePcm-QHQnu5tNjqGoFSoFqXgMm-xsSWmSspsWfTdvvpipaXvwIJ5mmPm-gfkJuQZ2C6DUHSScK0gAhBRJLKMTMtyNAhUyeXrou_2AXHi_ZKyjwvicDEIZhnHEYUje0rotg-evz9UKXalrOmlc1dRIdW1o6j16X2Hd0sbS2Vb_EC_o0W2RprZFd5zOm_eyoHOHut0Jl-TM6pXHq30dkdeH-_l4Ekxnj0_jdBoUQsg2kKAMt4ZHWmmBoIFzG0tjcqYFE4mWkChkKkKeiFwaq21sTahZXFgrcpXzEWH93cI13ju02dqVlXYfGbBsl1H2O6NOuemV9Sav0ByFQygdAD3gu1W9QJctm42ruzf-OhrsHb3Af_Df1al-4A</recordid><startdate>20150501</startdate><enddate>20150501</enddate><creator>Iwase, Akira</creator><creator>Nakamura, Tomoko</creator><creator>Nakahara, Tatsuo</creator><creator>Goto, Maki</creator><creator>Kikkawa, Fumitaka</creator><general>SAGE Publications</general><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20150501</creationdate><title>Anti-Müllerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment</title><author>Iwase, Akira ; Nakamura, Tomoko ; Nakahara, Tatsuo ; Goto, Maki ; Kikkawa, Fumitaka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-517d3fd36a7a4e1a133f85ddb0a4049a5197e076e394b5dfaf8fd2a08cff4b7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anti-Mullerian Hormone - blood</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Biomarkers - blood</topic><topic>Down-Regulation</topic><topic>Embryology</topic><topic>Female</topic><topic>Fertility Preservation</topic><topic>Humans</topic><topic>Infertility, Female - blood</topic><topic>Infertility, Female - chemically induced</topic><topic>Infertility, Female - physiopathology</topic><topic>Medicine & Public Health</topic><topic>Obstetrics/Perinatology/Midwifery</topic><topic>Ovarian Reserve - drug effects</topic><topic>Ovarian Reserve - radiation effects</topic><topic>Ovary - drug effects</topic><topic>Ovary - metabolism</topic><topic>Ovary - pathology</topic><topic>Ovary - physiopathology</topic><topic>Predictive Value of Tests</topic><topic>Radiation Injuries - blood</topic><topic>Radiation Injuries - etiology</topic><topic>Radiation Injuries - physiopathology</topic><topic>Radiotherapy - adverse effects</topic><topic>Reproductive Medicine</topic><topic>Review</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iwase, Akira</creatorcontrib><creatorcontrib>Nakamura, Tomoko</creatorcontrib><creatorcontrib>Nakahara, Tatsuo</creatorcontrib><creatorcontrib>Goto, Maki</creatorcontrib><creatorcontrib>Kikkawa, Fumitaka</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Reproductive sciences (Thousand Oaks, Calif.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iwase, Akira</au><au>Nakamura, Tomoko</au><au>Nakahara, Tatsuo</au><au>Goto, Maki</au><au>Kikkawa, Fumitaka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Müllerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment: A Systematic Narrative Review</atitle><jtitle>Reproductive sciences (Thousand Oaks, Calif.)</jtitle><stitle>Reprod. Sci</stitle><addtitle>Reprod Sci</addtitle><date>2015-05-01</date><risdate>2015</risdate><volume>22</volume><issue>5</issue><spage>519</spage><epage>526</epage><pages>519-526</pages><issn>1933-7191</issn><eissn>1933-7205</eissn><abstract>Since serum anti-Müllerian hormone (AMH) levels enable quantitative evaluation of ovarian damage, we conducted a computer-based search, using key words, of all articles published in English through the PubMed database from inception until September 2013 to summarize available studies evaluating ovarian reserve after ovarian toxic interventions to discuss the usefulness of serum AMH levels. We found that most of the studies demonstrated a decline in serum AMH levels when compared to control or pretreatment levels, with levels dependent on the type of treatment modality. Measurement of serum AMH levels enables quantitative evaluation of ovarian damage caused by ovarian toxic interventions, such as chemotherapy and radiotherapy, instead of qualitative evaluation using menstrual condition or basal follicle-stimulating hormone levels. Serum AMH levels are becoming indispensable to assess the ovarian reserve of patients who desire preservation of ovarian function for fertility and endogenous sex steroid hormones.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>25228631</pmid><doi>10.1177/1933719114549856</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1933-7191 |
| ispartof | Reproductive sciences (Thousand Oaks, Calif.), 2015-05, Vol.22 (5), p.519-526 |
| issn | 1933-7191 1933-7205 |
| language | eng |
| recordid | cdi_crossref_primary_10_1177_1933719114549856 |
| source | Springer Link |
| subjects | Anti-Mullerian Hormone - blood Antineoplastic Agents - adverse effects Biomarkers - blood Down-Regulation Embryology Female Fertility Preservation Humans Infertility, Female - blood Infertility, Female - chemically induced Infertility, Female - physiopathology Medicine & Public Health Obstetrics/Perinatology/Midwifery Ovarian Reserve - drug effects Ovarian Reserve - radiation effects Ovary - drug effects Ovary - metabolism Ovary - pathology Ovary - physiopathology Predictive Value of Tests Radiation Injuries - blood Radiation Injuries - etiology Radiation Injuries - physiopathology Radiotherapy - adverse effects Reproductive Medicine Review Risk Factors |
| title | Anti-Müllerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment: A Systematic Narrative Review |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A30%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-M%C3%BCllerian%20Hormone%20and%20Assessment%20of%20Ovarian%20Reserve%20After%20Ovarian%20Toxic%20Treatment:%20A%20Systematic%20Narrative%20Review&rft.jtitle=Reproductive%20sciences%20(Thousand%20Oaks,%20Calif.)&rft.au=Iwase,%20Akira&rft.date=2015-05-01&rft.volume=22&rft.issue=5&rft.spage=519&rft.epage=526&rft.pages=519-526&rft.issn=1933-7191&rft.eissn=1933-7205&rft_id=info:doi/10.1177/1933719114549856&rft_dat=%3Csage_cross%3E10.1177_1933719114549856%3C/sage_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-517d3fd36a7a4e1a133f85ddb0a4049a5197e076e394b5dfaf8fd2a08cff4b7b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/25228631&rft_sage_id=10.1177_1933719114549856&rfr_iscdi=true |